Interleukin-1β, tumor necrosis factor-α, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery

FASEB Journal

Volumn 10, Issue 7, 1996, Pages 785-791

  Wilkinson, M F ^a   Earle, M L ^a   Triggle, C R ^a   Barnes, S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

calcium channel; cytokine; endotoxin; immunomodulation; patch clamp

Indexed keywords

BARIUM ION; CALCIUM CHANNEL; CYCLIC AMP; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FORSKOLIN; INDOMETACIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; IMMUNOMODULATION; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; TAIL ARTERY; VASCULAR SMOOTH MUSCLE; ANIMAL; CHANNEL GATING; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT; TAIL; VASCULARIZATION;

ANIMALIA; ESCHERICHIA COLI;

ANIMALS; CALCIUM CHANNELS; CYCLIC AMP; CYCLIC GMP; DINOPROSTONE; DRUG INTERACTIONS; INTERLEUKIN-1; ION CHANNEL GATING; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; TAIL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030140042     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.7.8635696     Document Type: Article

References (32)

1. Dinarello, C. A. (1994) The interleukin-1 family: 10 years of discovery. FASEB J. 8, 1314-1325
2. Glauser, M. P., Baumgartner, J.-D., and Cohen, J. (1991) Septic shock: pathogenesis. Lancet 338, 732-735
3. Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., Deforge, L., Kenney, J. S., Remick, D. G., Bloedow, D. C., Thompson, R. C., Lowry, S. F., and Moldawer, L. L. (1992) Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89, 1551-1557
4. Alexander, H. R., Doherty, G. M., Venzon, D. J., Merino, M. J., Fraker, D. L., and Norton, J. A. (1992) Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery 112, 188-194
5. Wakabayashi, G., Gelfand, J. A., Burke, J. F., Thompson, R. C., and Dinarello, C. A. (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5, 338-343
6. Strieter, R. M., Kunkel, S. L., and Bone, R. C. (1993) Role of tumor necrosis factor-α in disease states and inflammation. Critical Care Med. 21, S447-S463
7. Derijk, R., and Berkenbosch, F. (1992) Development and application of a radioimmunoassay to detect interleukin-1 in rat peripheral circulation. Am. J. Physiol. 26, E1092-E1098
8. Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. A., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., Wilmore, D. W., Wolff, S. M., Burke, J. F., and Dinarello, C. A. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161, 79-84
9. Michie, H. A., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., and Wilmore, D. W. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Engl. J. Med. 318, 1481-1486
10. Spinas, G. A., Bloesch, D., Keller, U., Zimmerli, Z., and Cammisuli, S. (1991) Pretreatment with ibuprofen augments circulating tumor necrosis factor-α, interleukin-6, and elastase during acute endotoxinemia. J. Infect. Dis. 163, 89-95
11. Beutler, B., Milsark, I. W., and Cerami, A. C. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871
12. Hinshaw, L. B., Tekamp-Olson, P., Chang, A. C. K., Lee, A. T., Taylor, F. B., Jr., Murray, C. K., Peer, G. T., Emerson, T. E., Jr., Passey, R. B., and Kuo, G. C. (1990) Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis (TNFα). Circ. Shock 30, 279-292
13. Russell, D. A., Tucker, K. K., Chinookoswong, N., Thompson, R. C., and Kohuo, T. (1995) Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. J. Infect. Dis. 171, 1528-1538
14. Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., and Thompson, R. C. (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (London) 348, 550-552
15. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064
16. Wang, R., Karponski, E., and Pang, P. K. T. (1989) Two types of calcium channels in isolated smooth muscle cells from rat tail artery. Am. J. Physiol. 25, H1361-H1368
17. French, J. F., Schroeder, K. K., Akeson, A. L., Dage, R. C., and Bowlin, T. L. (1993) Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6. Eur. J. Physiol. 233, 109-112
18. Loppnow, H. (1994) LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms. Prog. Clin. Biol. Res. 388, 309-321
19. Fischer, E., Van Zee, K. J., Marano, M. A., Rock, C. S., Kenney, J. S., Poutsiaka, D. D., Dinarello, C. A., Lowry, S. F., and Moldawer, L. L. (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease. Blood 79, 2196-2200
20. Beasley, D., and Eldridge, M. (1994) Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am. J. Physiol. (Regulatory Integrative Comp. Physiol. 35), R1197-R1203
21. Busse, R., and M;aulsch, A. (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275, 87-90
22. Beasley, D., and McGuiggin, M. (1994) Interleukin-1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J. Exp. Med. 179, 71-80
23. Lee, H.-C., and Lum, B. K. B. (1986) Protective action of calcium entry blockers in endotoxin shock. Circ. Shock 18, 193-203
24. + channel in cultured vascular smooth muscle cells. J. Mol. Cell Cardiol. 26, 1487-1495
25. Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., and Dinarello, C. A. (1988) Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81, 1162-1172
26. Warner, S. J. C., and Libby, P. (1989) Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J. Immunol. 142, 100-109
27. Marks, Y. N., Dubyak, G. R., and Jones, S. W. (1990) Calcium current in the A7r5 smooth muscle-derived cell line. Pfluegers Arch. 417, 433-439
28. French, J. F., Lambert, L. E., and Dage, R. C. (1991) Nitric oxide synthase inhibitors inhibit interleukin-1β-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259, 260-264
29. Morimoto, K., Morimoto, A., Nakamori, T., Tan, N., Minagawa, T., and Murakami, N. (1992) Cardiovascular responses induced in free-moving rats by immune cytokines. J. Physiol. (London) 748, 307-320
30. Bataaillard, A., and Sassard, J. (1994) Cardiovascular effects of human recombinant interleukin-1β in conscious rats. Am. J. Physiol. 3, R1148-R1153
31. Mantovani, A., Bussolino, F., and Dejana, E. (1992) Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599
32. Clinton, S. K., Fleet, J. C., Loppnow, H., Salomon, R. N., Clark, B. D., Cannon, J. G., Shaw, A. R., Dinarello, C. A., and Libby, P. (1991) Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am. J. Pathol. 138, 1005-1014